Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Plus Therapeutics ( (PSTV) ) has shared an update.
Plus Therapeutics, Inc. held its 2026 Annual Meeting of Stockholders on May 14, 2026, with a quorum represented by 64,857,321 shares out of 171,550,698 outstanding as of the March 18, 2026 record date. Stockholders elected six directors to serve until the 2027 annual meeting, reinforcing continuity in the company’s leadership and governance.
Investors also ratified the appointment of CBIZ CPAs, P.C. as the independent registered public accounting firm for the 2026 fiscal year, supporting the company’s financial oversight framework. In addition, stockholders approved on an advisory basis the compensation of named executive officers and passed the sixth amendment and restatement of the 2020 Stock Incentive Plan, signaling support for existing executive pay practices and updated equity incentives.
The most recent analyst rating on (PSTV) stock is a Buy with a $50.00 price target. To see the full list of analyst forecasts on Plus Therapeutics stock, see the PSTV Stock Forecast page.
Spark’s Take on PSTV Stock
According to Spark, TipRanks’ AI Analyst, PSTV is a Neutral.
The score is held down primarily by very weak financial performance (zero 2025 revenue, widening losses, and heavy cash burn). Technicals provide some near-term support (price above 20/50DMA), but the longer-term trend remains negative (below 100/200DMA). Corporate events are a positive tailwind (FDA orphan designation and Nasdaq compliance), while valuation remains unattractive due to ongoing losses and no dividend.
To see Spark’s full report on PSTV stock, click here.
More about Plus Therapeutics
Plus Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics, operating within the healthcare sector and serving stockholders whose interests are represented through its publicly traded common stock. The company is governed by a board of directors elected by stockholders and supported by external auditors who oversee the integrity of its financial reporting.
Average Trading Volume: 319,595
Technical Sentiment Signal: Sell
Current Market Cap: $39.53M
Find detailed analytics on PSTV stock on TipRanks’ Stock Analysis page.